Yasmin can be taken while travelling, but it is advisable to carry the medication in its original packaging, along with a copy of the prescription, to facilitate security checks. Keep the tablets in a temperature-controlled environment; avoid extreme heat.
Non-steroidal anti-inflammatory drugs (NSAIDs) such as ibuprofen do not diminish contraceptive efficacy, but combined use may increase the risk of gastrointestinal bleeding. Use the lowest effective NSAID dose and consider a proton-pump inhibitor if prolonged use is required.
If vomiting occurs within two hours of ingestion, repeat the missed dose as soon as possible and discard the remaining tablets from that day. Use a barrier method (e.g., condom) for the next 24 hours.
St John’s wort, a herbal supplement used for mood, can induce CYP3A4 enzymes and lower estrogen levels, potentially reducing contraceptive protection. Discuss all supplement use with a pharmacist or prescriber.
Yasmin is approved in the UK for moderate acne that has not responded to topical therapy. The anti-androgenic activity of drospirenone helps reduce sebum production, improving skin appearance over several months.
Smoking, especially > 15 cigarettes per day in women aged ≥ 35 years, significantly raises the risk of VTE and arterial thrombotic events when combined with estrogen-containing contraceptives. Smoking cessation is strongly recommended.
Yasmin is not recommended during breastfeeding because estrogen can reduce milk production and expose the infant to low levels of hormones. Progestogen-only methods or non-hormonal options are preferred.
Yasmin’s distinctive feature is the inclusion of drospirenone, which possesses anti-mineralocorticoid activity, potentially reducing water retention compared with older progestogens. However, overall efficacy and safety profiles are comparable to other COCs when used correctly.
When moving from one COC to another, it is generally safe to start Yasmin the day after finishing the last active tablet of the previous pack, provided the previous regimen was taken correctly. A brief gap may be advised if the prior pill contained a higher estrogen dose.
Most women experience a regular withdrawal bleed after the first cycle. Minor spotting may persist for 2-3 months as the endometrium stabilises. If irregular bleeding continues beyond six months, a medical review is warranted.
Yasmin is a combined oral contraceptive (COC) that contains the synthetic progestogen drospirenone (3 mg) and the estrogen ethinyl estradiol (0.03 mg) in a single pill. It is marketed in the United Kingdom under the brand name Yasmin and is prescribed by healthcare professionals for the prevention of pregnancy and for certain menstrual-related indications. The product is a prescription-only medicine (POM) regulated by the Medicines and Healthcare products Regulatory Agency (MHRA).
Yasmin belongs to the class of combined hormonal contraceptives. The two active ingredients act together to prevent ovulation:
Together, the hormones maintain consistent plasma levels that:
Onset of contraceptive effect occurs after the first active pill if taken correctly; a backup method is advised during the first seven days of a new pack.
Yasmin is approved in the UK for:
These indications are supported by MHRA-approved product information and clinical guidelines for combined oral contraceptives.
When in doubt, clinicians assess individual risk factors before initiating therapy.
Any of the above require immediate medical attention.
Patients should disclose all prescription, over-the-counter, herbal, and dietary supplements before starting Yasmin.
Never double a dose without professional guidance.
This article provides educational information about Yasmin and is not a substitute for professional medical advice. Treatment decisions, including use for unapproved indications, must be made under the guidance of a qualified healthcare provider. The content is intended for informational purposes and does not constitute medical recommendations. Always consult a physician before starting, stopping, or changing any medication regimen.
